Newest
PEBO ▼ sold $76K · Augenstein Mark filed 1d agoBBT ▲ bought $105K · Hollister Thomas J filed 2d agoBBT ▼ sold $20K · Eagan John Buckley filed 2d agoGS ▼ sold $60K · LESLIE ERICKA T filed 2d agoGS ▼ sold $163K · LESLIE ERICKA T filed 2d agoMSCI ▼ sold $1.5M · Gutowski Robert J. filed 2d agoGL ▼ sold $2.2M · MAJORS MICHAEL CLAY filed 2d agoPHR ▲ bought $362 · Linetsky David filed 2d agoPHR ▲ bought $320 · Linetsky David filed 2d agoRVI ▲ bought $23K · Whitney Meredith filed 2d agoLEO ▲ bought $369K · Saba Capital Management, L.P. filed 2d agoPG ▼ sold $5.7M · Jejurikar Shailesh filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoICLR ▼ sold $15K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoPG ▼ sold $698K · Gama Paul filed 2d ago

Insider / BIOCRYST PHARMACEUTICALS INC

Barnes Alane P

Chief Legal Officer at BIOCRYST PHARMACEUTICALS INC

Company
BIOCRYST PHARMACEUTICALS INC
Ticker
BCRX
First filing on record
December 3, 2025
Latest trade on record
May 13, 2026
SEC filings
EDGAR ↗

Barnes Alane P, Chief Legal Officer at BIOCRYST PHARMACEUTICALS INC, has disclosed 17 transactions in BCRX since December 3, 2025: 0 purchases (0 open-market buys) and 9 sales, worth about $5.1M at the reported prices. The latest was filed May 15, 2026, 2 days after the trade.

Last updated May 15, 2026 · Source: SEC EDGAR Form 4 filings

Transactions
17
Open-market buys
0
Sales
9
Avg. disclosure lag
1.9d

Trading in charts

Trade timeline

When does this person trade, how big, and in which direction? Every trade in the last 12 months.

Bought (above the line)Sold (below the line)Other transaction
Oct 25NovDecJan 26FebMarAprMayJunJulAugSep
Oct 25NovDecJan 26FebMarAprMayJunJulAugSep

In the last 12 months Barnes Alane P made no purchases and 9 sales worth $3.7M, plus 8 other transactions. Dot size is the dollar amount.

Portfolio mix

Which stocks does this person trade most? Tile size is dollars traded, all time on record.

BCRX$3.7M
BCRX$3.7M

Barnes Alane P has traded 1 stock on record; the largest by dollars is BCRX.

Reporting lag

Does this person report on time? One bar per filing against the Form 4 deadline.

On timeLate
Form 4 deadlineoldest filingnewest

0 of 6 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).

What kind of transactions

Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.

Rows by Form 4 transaction code
CodeMeaningRowsSharesValue
SOpen-market sale7417,163$3.5M
MOption exercise or conversion6607,008$1.4M
AGrant or award2376,750—
FShares withheld for tax225,442$190K
Rows by year of the trade
YearRowsBoughtSold
2026602 · $2.0M
20251107 · $1.7M

Transactions

Download BCRX trades (CSV)85 rows · 30 KB · every filer in this ticker, this insider included · all downloads

SecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
BCRXOption / conversion MMay 13, 2026May 15, 20262d62,500——10b5-1 planderivativeForm 4 ↗
BCRXSell SMay 13, 2026May 15, 20262d62,500$10$596K10b5-1 planForm 4 ↗
BCRXOption / conversion MMay 13, 2026May 15, 20262d62,500$5$315K10b5-1 planForm 4 ↗
BCRXOption / conversion MMarch 16, 2026March 18, 20262d150,000——10b5-1 planderivativeForm 4 ↗
BCRXSell SMarch 16, 2026March 18, 20262d150,000$9$1.4M10b5-1 planForm 4 ↗
BCRXOption / conversion MMarch 16, 2026March 18, 20262d150,000$6$827K10b5-1 planForm 4 ↗
BCRXSell SDecember 22, 2025December 23, 20251d21,773$8$167K10b5-1 planForm 4 ↗
BCRXSell FDecember 19, 2025December 23, 20254d16,902$7$125K10b5-1 planForm 4 ↗
BCRXOther ADecember 17, 2025December 19, 20252d255,050——derivativeForm 4 ↗
BCRXOther ADecember 17, 2025December 19, 20252d121,700——Form 4 ↗
BCRXSell SDecember 15, 2025December 16, 20251d21,210$8$162K10b5-1 planForm 4 ↗
BCRXSell FDecember 12, 2025December 16, 20254d8,540$8$65K10b5-1 planForm 4 ↗
BCRXOption / conversion MDecember 1, 2025December 3, 20252d91,004——10b5-1 planderivativeForm 4 ↗
BCRXSell SDecember 3, 2025December 3, 20250d19,770$8$151K10b5-1 planForm 4 ↗
BCRXSell SDecember 2, 2025December 3, 20251d50,906$7$367K10b5-1 planForm 4 ↗
BCRXSell SDecember 1, 2025December 3, 20252d91,004$7$647K10b5-1 planForm 4 ↗
BCRXOption / conversion MDecember 1, 2025December 3, 20252d91,004$3$293K10b5-1 planForm 4 ↗

Filings

FiledFormAccessionRowsStatusSource
May 15, 2026Form 40000882796-26-0000213publishedEDGAR ↗
March 18, 2026Form 40000882796-26-0000153publishedEDGAR ↗
December 23, 2025Form 40000882796-25-0000432publishedEDGAR ↗
December 19, 2025Form 40001171843-25-0080372publishedEDGAR ↗
December 16, 2025Form 40000882796-25-0000332publishedEDGAR ↗
December 3, 2025Form 40000882796-25-0000275publishedEDGAR ↗

Other insiders at BIOCRYST PHARMACEUTICALS INC

Everyone on file, with contracts and lobbying under the company's name: BIOCRYST PHARMACEUTICALS INC.

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 4617December 3, 2025May 15, 2026Form 4 list on EDGAR

Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.

Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.